Relapsed and Refractory B-cell Lymphoma
2 clinical trials · Condition
◉ Watch Relapsed and Refractory B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma (NCT05585996) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-08-01 |
| The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma (NCT04169932) | Shanghai Longyao Biotechnology Inc., Ltd. | 2019-11-22 |
Track Relapsed and Refractory B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.